CERo Therapeutics Holdings, Inc.
CERO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14 | $162 | $151 | $146 |
| - Cash | $3 | $2 | $42 | $1 |
| + Debt | $2 | $2 | $1 | $4 |
| Enterprise Value | $13 | $162 | $110 | $148 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$2 | -$0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$0 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -6.87 | -2,497.2 | -19.73 | -2.75 |
| % Growth | 99.7% | -12,556.9% | -617.5% | – |
| Operating Cash Flow | -$6 | -$6 | -$1 | -$1 |
| Capital Expenditures | $0 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$6 | -$6 | -$2 | -$1 |